cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Exact Sciences Corporation
103 own
30 watching
Current Price
$45.3
$-3.06
(-6.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
8,209.73M
52-Week High
52-Week High
99.56000
52-Week Low
52-Week Low
40.62000
Average Volume
Average Volume
3.68M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization8,209.73M
icon52-Week High99.56000
icon52-Week Low40.62000
iconAverage Volume3.68M
iconDividend Yield--
iconP/E Ratio--
What does the Exact Sciences Corporation do?
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Read More
How much money does Exact Sciences Corporation make?
News & Events about Exact Sciences Corporation.
Benzinga
1 year ago
Tuesday,Exact Sciences Corp(NASDAQ: EXAS) announced topline results from the pivotal BLUE-C study, showing that next-generation Latest Ratings for EXAS DateFirmActionFromTo Feb 2022Wells FargoMaintainsEqual-Weight Feb 2022CitigroupMaintainsNeutral Feb 2022Raymond JamesMaintainsOutperform View ...
PR Newswire
1 year ago
Thinking about trading options or stock in Tesla, Microsoft, Exact Sciences, Coinbase Global, or Logitech International? Thinking about trading options or stock in Tesla, Microsoft, Exact Sciences, Coinbase Global, or Logitech International? PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21...
Zolmax
1 year ago
Exact Sciences (NASDAQ:EXAS Get Rating) and CareDx (NASDAQ:CDNA Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and ...
PR Newswire
1 year ago
Exact Sciences schedules first quarter 2023 earnings call Exact Sciences schedules first quarter 2023 earnings call PR Newswire MADISON, Wis., April 10, 2023 MADISON, Wis., April 10, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic...
TheStreet.com - Investing
1 year ago
Her flagship Ark Innovation ETF has slumped 38% over the past year, but has rebounded 23% so far this year.Her flagship Ark Innovation ETF has slumped 38% over the past year, but has rebounded 23% so far this year.If youve followed Cathie Woods trades in recent months, youve undoubtedly noticed that...
Frequently Asked Questions
Frequently Asked Questions
What is Exact Sciences Corporation share price today?
plus_minus_icon
Can Indians buy Exact Sciences Corporation shares?
plus_minus_icon
How can I buy Exact Sciences Corporation shares from India?
plus_minus_icon
Can Fractional shares of Exact Sciences Corporation be purchased?
plus_minus_icon
What are the documents required to start investing in Exact Sciences Corporation stocks?
plus_minus_icon
What is today’s traded volume of Exact Sciences Corporation?
plus_minus_icon
What is today’s market capitalisation of Exact Sciences Corporation?
plus_minus_icon
What is the 52-Week High and Low Range of Exact Sciences Corporation?
plus_minus_icon
What percentage is Exact Sciences Corporation down from its 52-Week High?
plus_minus_icon
What percentage is Exact Sciences Corporation up from its 52-Week Low?
plus_minus_icon
Current Price
$45.3
$-3.06
(-6.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
National HealthCare Corporation
National HealthCare Corporation
$135.68
$4.89 (3.74 %)
Medpace Holdings, Inc.
Medpace Holdings, Inc.
$381.93
$1.43 (0.38 %)
Gen Digital Inc.
Gen Digital Inc.
$26.10
$0.89 (3.53 %)
NeoGenomics, Inc.
NeoGenomics, Inc.
$14.87
$-0.21 (-1.39 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
National HealthCare Corporation
National HealthCare Corporation
$135.68
$4.89 (3.74 %)
Medpace Holdings, Inc.
Medpace Holdings, Inc.
$381.93
$1.43 (0.38 %)
Gen Digital Inc.
Gen Digital Inc.
$26.10
$0.89 (3.53 %)
NeoGenomics, Inc.
NeoGenomics, Inc.
$14.87
$-0.21 (-1.39 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00